Vestmark Advisory Solutions Inc. Has $3.31 Million Stock Position in Chemed Corporation $CHE

Vestmark Advisory Solutions Inc. increased its stake in Chemed Corporation (NYSE:CHEFree Report) by 22.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,392 shares of the company’s stock after buying an additional 1,338 shares during the quarter. Vestmark Advisory Solutions Inc. owned approximately 0.05% of Chemed worth $3,310,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in CHE. Personal CFO Solutions LLC raised its position in Chemed by 19.5% during the third quarter. Personal CFO Solutions LLC now owns 650 shares of the company’s stock worth $291,000 after acquiring an additional 106 shares in the last quarter. Mendel Money Management acquired a new position in shares of Chemed during the 3rd quarter worth about $697,000. Syon Capital LLC bought a new stake in shares of Chemed in the 3rd quarter valued at about $212,000. Maridea Wealth Management LLC acquired a new stake in Chemed in the 3rd quarter valued at about $527,000. Finally, GSA Capital Partners LLP bought a new position in Chemed during the third quarter worth about $273,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Stock Performance

Shares of Chemed stock opened at $479.09 on Tuesday. The firm has a 50-day moving average of $445.75 and a 200-day moving average of $443.99. Chemed Corporation has a 52-week low of $408.42 and a 52-week high of $623.60. The stock has a market cap of $6.78 billion, a PE ratio of 25.34, a PEG ratio of 2.32 and a beta of 0.44.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, February 23rd. Chemed’s dividend payout ratio is presently 12.69%.

Wall Street Analyst Weigh In

CHE has been the topic of several research analyst reports. Royal Bank Of Canada dropped their price objective on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $555.50.

View Our Latest Research Report on CHE

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

See Also

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.